
    
      The investigators hope to get preliminary results for the breast cancer patients who are
      given different neoadjuvant chemothetapy regimens. The patients are randomized two
      chemotherapy regimens. One is anthracyclines plus taxanes for 6-8 cycles,the other is
      anthracyclines plus taxanes for 3-4 cycles ,then switch tovinorelbine plus cisplatinum for
      3-4 cycles.
    
  